Shin-Hyung Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shin-Hyung Park has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Yung Hyun Choi
Department of Biochemistry, Dong-eui University College of Korean Medicine, Busan, Republic of Korea
13 shared publications Hyun-Ji Park
Department of Pathology, College of Korean Medicine, Dong-eui University
11 shared publications- Hyun-Ji Park
Department of Pathology, College of Korean Medicine, Dong-eui University, Busan 47227, Republic of Korea
6 shared publications Jae-Hoon Jeong
Department of Pathology, College of Korean Medicine, Dong-eui University
4 shared publications- Jae-Hoon Jeong
Department of Pathology, College of Korean Medicine, Dong-eui University, Busan 47227, Republic of Korea
4 shared publications - Cheol Park
Department of Molecular Biology, College of Natural Sciences, Dong-eui University, Busan 47340, Republic of Korea
3 shared publications
Latest Publications
- 7 July 2026
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 78 (7) , 550-565
Ethanolic Extract of Bupleurum Falcatum L. Root Attenuates Chronic Stress-Induced Cancer Metastasis via Inhibition of Src Kinase
Psychological stress has been increasingly recognized as a critical contributor to cancer progression, particularly in facilitating metastatic dissemination (1,2). Chronic activation of the hypotha...
- 7 July 2026
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 78 (7) , 550-565
Ethanolic Extract of Bupleurum Falcatum L. Root Attenuates Chronic Stress-Induced Cancer Metastasis via Inhibition of Src Kinase
Psychological stress has been increasingly recognized as a critical contributor to cancer progression, particularly in facilitating metastatic dissemination (1,2). Chronic activation of the hypotha...
- 6 July 2026
- Published by Elsevier in Fitoterapia
- Vol. 193, 107373
Bupleurum falcatum L. root extract suppresses norepinephrine-induced M2 macrophage polarization by regulating IL-4/STAT6 axis
- 6 July 2026
- Published by Elsevier in Fitoterapia
- Vol. 193, 107373
Bupleurum falcatum L. root extract suppresses norepinephrine-induced M2 macrophage polarization by regulating IL-4/STAT6 axis
- 4 July 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (13) , 20465-20476
Rosmarinic acid inhibits norepinephrine-induced metastatic capacity of triple negative breast cancer cells by Src kinase inactivation
Chronic psychological stress promotes cancer metastasis through catecholamine-mediated activation of β-adrenergic signaling. This study aimed to evaluate the inhibitory effects of rosmarinic acid (RA) on norepinephrine (NE)-induced migration and invasion in triple-negative breast cancer (TNBC) cells and to elucidate the underlying molecular mechanisms. Cell viability was assessed using an MTT assay. Migration and invasion were evaluated by Transwell assays in MDA-MB-231 and BT-20 cells treated with NE in the presence or absence of RA. Src phosphorylation and EMT-related protein expression were analyzed by Western blotting. Molecular docking was performed to predict the binding of RA to Src kinase. Constitutively active Src transfection was used to confirm the role of Src. A network pharmacology-based analysis was conducted to identify RA-associated targets and enriched pathways. RA significantly suppressed NE-induced migration and invasion in TNBC cells. RA markedly reduced NE-induced Src phosphorylation, and docking analysis predicted stable binding of RA within the ATP-binding pocket of Src. Constitutive Src activation abrogated the anti-migratory and anti-invasive effects of RA, confirming Src as a key molecular target. RA also attenuated NE-induced EMT by reducing mesenchymal marker expression. Network pharmacology analysis revealed enrichment of RA-associated targets in cancer-related pathways and identified several hub genes that converge on Src-related signaling cascades. RA suppresses NE-induced metastatic phenotypes in TNBC cells primarily through inhibition of Src kinase and partial modulation of the EMT program, highlighting its potential as a therapeutic candidate for stress-associated TNBC metastasis.
- 4 July 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (13) , 20465-20476
Rosmarinic acid inhibits norepinephrine-induced metastatic capacity of triple negative breast cancer cells by Src kinase inactivation
Chronic psychological stress promotes cancer metastasis through catecholamine-mediated activation of β-adrenergic signaling. This study aimed to evaluate the inhibitory effects of rosmarinic acid (RA) on norepinephrine (NE)-induced migration and invasion in triple-negative breast cancer (TNBC) cells and to elucidate the underlying molecular mechanisms. Cell viability was assessed using an MTT assay. Migration and invasion were evaluated by Transwell assays in MDA-MB-231 and BT-20 cells treated with NE in the presence or absence of RA. Src phosphorylation and EMT-related protein expression were analyzed by Western blotting. Molecular docking was performed to predict the binding of RA to Src kinase. Constitutively active Src transfection was used to confirm the role of Src. A network pharmacology-based analysis was conducted to identify RA-associated targets and enriched pathways. RA significantly suppressed NE-induced migration and invasion in TNBC cells. RA markedly reduced NE-induced Src phosphorylation, and docking analysis predicted stable binding of RA within the ATP-binding pocket of Src. Constitutive Src activation abrogated the anti-migratory and anti-invasive effects of RA, confirming Src as a key molecular target. RA also attenuated NE-induced EMT by reducing mesenchymal marker expression. Network pharmacology analysis revealed enrichment of RA-associated targets in cancer-related pathways and identified several hub genes that converge on Src-related signaling cascades. RA suppresses NE-induced metastatic phenotypes in TNBC cells primarily through inhibition of Src kinase and partial modulation of the EMT program, highlighting its potential as a therapeutic candidate for stress-associated TNBC metastasis.
- Open Access
- 31 December 2025
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 28 (4) , 290-300
Inhibition of Adrenergic Agonist–Induced Metastatic Potential in Cancer Cells by an Ethanolic Extract of Lindera aggregata Root Tuber
Jae-Hoon Jeong, Shin-Hyung Park. J Pharmacopuncture 2025;28:290-300. https://doi.org/10.3831/KPI.2025.28.4.290
- 31 December 2025
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 28 (4) , 290-300
Open AccessInhibition of Adrenergic Agonist–Induced Metastatic Potential in Cancer Cells by an Ethanolic Extract of Lindera aggregata Root Tuber
Jae-Hoon Jeong, Shin-Hyung Park. J Pharmacopuncture 2025;28:290-300. https://doi.org/10.3831/KPI.2025.28.4.290
- 17 November 2025
- Published by Elsevier in Fitoterapia
- Vol. 188, 106990
Dual inhibition of angiogenesis by Peucedanum praeruptorum Dunn root extract in endothelial and gefitinib-resistant lung cancer cells
- 17 November 2025
- Published by Elsevier in Fitoterapia
- Vol. 188, 106990
Dual inhibition of angiogenesis by Peucedanum praeruptorum Dunn root extract in endothelial and gefitinib-resistant lung cancer cells
- 23 July 2025
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 772, 110561
Deoxypodophyllotoxin induces apoptosis in non-small cell lung cancer cells by targeting the glucocorticoid receptor
- 23 July 2025
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 772, 110561
Deoxypodophyllotoxin induces apoptosis in non-small cell lung cancer cells by targeting the glucocorticoid receptor
- Open Access
- 30 June 2025
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 28 (2) , 144-153
Suppression of Macrophage Migration and M2 Polarization by an Ethanolic Extract of Scutellaria baicalensis Root
Hyun-Ji Park, Shin-Hyung Park. J Pharmacopuncture 2025;28:144-53. https://doi.org/10.3831/KPI.2025.28.2.144
- 30 June 2025
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 28 (2) , 144-153
Open AccessSuppression of Macrophage Migration and M2 Polarization by an Ethanolic Extract of Scutellaria baicalensis Root
Hyun-Ji Park, Shin-Hyung Park. J Pharmacopuncture 2025;28:144-53. https://doi.org/10.3831/KPI.2025.28.2.144
- 28 November 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 741, 151087
Norepinephrine stimulates M2 macrophage polarization via β2-adrenergic receptor-mediated IL-6 production in breast cancer cells
- 28 November 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 741, 151087
Norepinephrine stimulates M2 macrophage polarization via β2-adrenergic receptor-mediated IL-6 production in breast cancer cells
- Open Access
Hexane Fraction of Adenophora triphylla var. japonica Root Extract Inhibits Angiogenesis and Endothelial Cell-Induced Erlotinib Resistance in Lung Cancer Cells
The aim of this study was to investigate the anti-angiogenic effects of the hexane fraction of Adenophora triphylla var. japonica root extract (HAT) and its influence on the development of erlotinib resistance in human lung cancer cells. HAT significantly reduced the migration, invasion, and tube formation of human umbilical vein endothelial cells (HUVECs). The phosphorylation levels of vascular endothelial growth factor receptor 2 (VEGFR2) and its downstream molecules were decreased via HAT, indicating its anti-angiogenic potential in endothelial cells (ECs). A docking analysis demonstrated that β-sitosterol and lupeol, representative components of HAT, exhibit a high affinity for binding to VEGFR2. In addition, conditioned media from HAT-pretreated H1299 human lung cancer cells attenuated cancer-cell-induced chemotaxis of HUVECs, which was attributed to the decreased expression of angiogenic and chemotactic factors in H1299 cells. Interestingly, co-culture of erlotinib-sensitive PC9 human lung cancer cells with HUVECs induced erlotinib resistance in PC9 cells. However, co-culture with HAT-pretreated HUVECs partially restored the sensitivity of PC9 cells to erlotinib. HAT inhibited the development of erlotinib resistance by attenuating hepatocyte growth factor (HGF) production by ECs. Taken together, our results demonstrate that HAT exerts its anticancer effects by regulating the crosstalk between ECs and lung cancer cells.
Open AccessHexane Fraction of Adenophora triphylla var. japonica Root Extract Inhibits Angiogenesis and Endothelial Cell-Induced Erlotinib Resistance in Lung Cancer Cells
The aim of this study was to investigate the anti-angiogenic effects of the hexane fraction of Adenophora triphylla var. japonica root extract (HAT) and its influence on the development of erlotinib resistance in human lung cancer cells. HAT significantly reduced the migration, invasion, and tube formation of human umbilical vein endothelial cells (HUVECs). The phosphorylation levels of vascular endothelial growth factor receptor 2 (VEGFR2) and its downstream molecules were decreased via HAT, indicating its anti-angiogenic potential in endothelial cells (ECs). A docking analysis demonstrated that β-sitosterol and lupeol, representative components of HAT, exhibit a high affinity for binding to VEGFR2. In addition, conditioned media from HAT-pretreated H1299 human lung cancer cells attenuated cancer-cell-induced chemotaxis of HUVECs, which was attributed to the decreased expression of angiogenic and chemotactic factors in H1299 cells. Interestingly, co-culture of erlotinib-sensitive PC9 human lung cancer cells with HUVECs induced erlotinib resistance in PC9 cells. However, co-culture with HAT-pretreated HUVECs partially restored the sensitivity of PC9 cells to erlotinib. HAT inhibited the development of erlotinib resistance by attenuating hepatocyte growth factor (HGF) production by ECs. Taken together, our results demonstrate that HAT exerts its anticancer effects by regulating the crosstalk between ECs and lung cancer cells.
- 7 January 2024
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 76 (3) , 305-315
The Ethanolic Extract of Dictyopteris Divaricata Induces Apoptosis in Non-Small Cell Lung Cancer Cells by Inhibiting STAT3 Activity
Dictyopteris divaricata (DD) has been reported to exert diverse pharmacological activities, including anti-inflammatory, antioxidant, and anticancer effects. In this study, we aimed to investigate the anticancer potential of the ethanolic extract of DD (EDD) in non-small cell lung cancer (NSCLC) cells and to explore the underlying mechanism. EDD significantly suppressed cell proliferation in H1299, PC9, and H1975 NSCLC cells. EDD treatment increased the proportion of Annexin V-positive cells and cells in sub-G1 phase, indicating the induction of apoptosis. This observation was further supported by the presence of fragmented nuclei and increased expression of cleaved PARP and cleaved caspase-3 in NSCLC cells following EDD treatment. Mechanistically, EDD decreased the phosphorylation levels of signal transducer and activator of transcription 3 (STAT3) and Src. Transfection of constitutively activated STAT3 into H1975 cells partially attenuated EDD-induced apoptosis, highlighting the contribution of STAT3 inhibition to the anticancer activity of EDD. In addition, we identified fucosterol as a major constituent of EDD that exhibited similar anticancer potential in NSCLC cells. Taken together, our results demonstrate that EDD induces apoptosis in NSCLC cells by inhibiting STAT3 activity. We propose EDD as a potential candidate for the development of therapies targeting NSCLC.
- 7 January 2024
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 76 (3) , 305-315
The Ethanolic Extract of Dictyopteris Divaricata Induces Apoptosis in Non-Small Cell Lung Cancer Cells by Inhibiting STAT3 Activity
Dictyopteris divaricata (DD) has been reported to exert diverse pharmacological activities, including anti-inflammatory, antioxidant, and anticancer effects. In this study, we aimed to investigate the anticancer potential of the ethanolic extract of DD (EDD) in non-small cell lung cancer (NSCLC) cells and to explore the underlying mechanism. EDD significantly suppressed cell proliferation in H1299, PC9, and H1975 NSCLC cells. EDD treatment increased the proportion of Annexin V-positive cells and cells in sub-G1 phase, indicating the induction of apoptosis. This observation was further supported by the presence of fragmented nuclei and increased expression of cleaved PARP and cleaved caspase-3 in NSCLC cells following EDD treatment. Mechanistically, EDD decreased the phosphorylation levels of signal transducer and activator of transcription 3 (STAT3) and Src. Transfection of constitutively activated STAT3 into H1975 cells partially attenuated EDD-induced apoptosis, highlighting the contribution of STAT3 inhibition to the anticancer activity of EDD. In addition, we identified fucosterol as a major constituent of EDD that exhibited similar anticancer potential in NSCLC cells. Taken together, our results demonstrate that EDD induces apoptosis in NSCLC cells by inhibiting STAT3 activity. We propose EDD as a potential candidate for the development of therapies targeting NSCLC.